Analystreport

Globus Medical Inc (NYSE: GMED) had its price target raised by analysts at UBS Group AG from $61.00 to $67.00. They now have a "buy" rating on the stock.

Globus Medical, Inc. Class A  (GMED) 
Last globus medical, inc. class a earnings: 2/20 04:15 pm Check Earnings Report
US:NYSE Investor Relations: investors.globusmedical.com